I welcome hearing from you
Diabetes Care 43(7):16361649
Commenting on their vision, the Co-Founder and Managing Partner of Corridor Ventures, Kwamena Aidoo, commented that Connecting wearable device and electronic health records data has the potential to transform clinical research insights and evolve the way health and wellness care is administered across the globe. They continue, suggesting that Patientory sits at the forefront of this movement
Research efforts have focused on the regulation of the GLP-1R mediated signaling pathway as a therapeutic approach to type 2 diabetes (T2DM) and have resulted in the development of several GLP-1 FDA-approved agonists
GLP-1 receptor agonist peptides are synthetic compounds designed to replicate or enhance the effects of glucagon-like peptide-1 (GLP-1), an incretin hormone released by the gut after eating
GLP-1 also regulates gastric motility by slowing gastric emptying in a dose-dependent manner, helping to control postprandial glucose levels